Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cayla J Saret

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 11, 2013
Is the US "leading from behind" on health policy?Peter J Neumann, Cayla J Saret
Expert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topicsPeter J Neumann, Cayla J Saret
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
When Does FDAMA Section 114 Apply? Ten Case StudiesPeter J Neumann, Cayla J Saret
Cancer|August 8, 2015
Price and value in cancer careCayla J Saret, Joshua T Cohen, Susan K Parsons, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
The changing face of the cost-utility literature, 1990-2012Peter J Neumann, Teja Thorat, Jennifer Shi, et al.
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 10, 2019
Social Participation of Burn Survivors and the General Population in Work and Employment: A Life Impact Burn Recovery Evaluation (LIBRE) Profile StudyCayla J Saret, Pengsheng Ni, Molly Marino, et al.
International Journal of Technology Assessment in Health Care|October 26, 2017
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTSJames D Chambers, Cayla J Saret, Jordan E Anderson, et al.
Blood|February 7, 2015
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analysesCayla J Saret, Aaron N Winn, Gunjan Shah, et al.
Plos One|December 23, 2016
A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY AvertedPeter J Neumann, Teja Thorat, Yue Zhong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 11, 2013
Is the US "leading from behind" on health policy?Peter J Neumann, Cayla J Saret
Expert Review of Pharmacoeconomics & Outcomes Research|October 22, 2013
A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topicsPeter J Neumann, Cayla J Saret
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2015
When Does FDAMA Section 114 Apply? Ten Case StudiesPeter J Neumann, Cayla J Saret
Cancer|August 8, 2015
Price and value in cancer careCayla J Saret, Joshua T Cohen, Susan K Parsons, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
The changing face of the cost-utility literature, 1990-2012Peter J Neumann, Teja Thorat, Jennifer Shi, et al.
Pharmacoeconomics|July 28, 2016
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation StudyPei-Jung Lin, Cayla J Saret, Peter J Neumann, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|May 10, 2019
Social Participation of Burn Survivors and the General Population in Work and Employment: A Life Impact Burn Recovery Evaluation (LIBRE) Profile StudyCayla J Saret, Pengsheng Ni, Molly Marino, et al.
International Journal of Technology Assessment in Health Care|October 26, 2017
EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTSJames D Chambers, Cayla J Saret, Jordan E Anderson, et al.
Blood|February 7, 2015
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analysesCayla J Saret, Aaron N Winn, Gunjan Shah, et al.
Plos One|December 23, 2016
A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY AvertedPeter J Neumann, Teja Thorat, Yue Zhong, et al.
Pageof 1